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Abstract
Single-cell measurement techniques can now probe gene expression in heterogeneous cell popula-
tions from the human body across a range of environmental and physiological conditions. How-
ever, new mathematical and computational methods are required to represent and analyze gene ex-
pression changes that occur in complex mixtures of single cells as they respond to signals, drugs,
or disease states. Here, we introduce a mathematical modeling platform, PopAlign, that automati-
cally identifies subpopulations of cells within a heterogeneous mixture, and tracks gene expression
and cell abundance changes across subpopulations by constructing and comparing probabilistic
models. We apply PopAlign to discover specific categories of signaling responses within primary
human immune cells as well as patient-specific disease signatures in multiple myeloma that are
obscured by techniques like tSNE. We anticipate that PopAlign will enable large scale studies of
natural and engineered cell populations as they respond to drugs, signals or physiological change.
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Introduction
All physiological processes in the body are driven by heterogeneous populations of single cells
[1, 2, 3]. Single-cell measurement technologies can now profile gene expression in thousands of
cells from heterogeneous cell populations across different tissues, physiological conditions, and
disease states. However, converting single cell data into models that provide a‘population-level
understanding of processes like an immune response to infection or cancer progression remains a
fundamental challenge. All human tissues contain many different subpopulations of cells, and each
subpopulation can undergo distinct changes in gene expression and cellular abundance in response
to signals, drugs, or environmental conditions. New conceptual and mathematical frameworks are
required to model and track the changes that occur within distinct subpopulations of cells within a
heterogeneous tissue as they respond to perturbations or succumb to disease.
In this paper, we introduce a computational framework, PopAlign, that identifies, aligns, and
tracks subpopulations of single cells within a heterogeneous cell population profiled by single
cell mRNA-seq [4, 5, 2, 6]. Mathematically, PopAlign constructs a probabilistic model of each
cell population across a series of samples. PopAlign (a) automatically identifies and models sub-
populations of cells (b) aligns cellular subpopulations across experimental conditions (signaling,
disease) and (c) quantifies changes in cell abundance and gene expression for all aligned subpopu-
lations of cells.
The key conceptual advance underlying PopAlign is representational: we model the distribution of
gene expression states within a heterogeneous cell population using a probabilistic mixture model
that we infer from single cell data. PopAlign identifies and represents subpopulations of cells as
independent Gaussian densities within a reduced gene expression space. PopAlign, then, makes
quantitative statistical alignments between subpopulations across samples, and thus enables tar-
geted and quantitative comparisons in gene expression state and cellular abundance. Probabilistic
modeling is enabled by a novel low dimensional representation of cell-state in terms of a set of
gene expression features learned from data [7, 8, 9].
PopAlign identifies shifts in cell-state that are obscured or even lost by existing techniques like
tSNE. Geometric methods like tSNE can reveal subpopulations of cells within a mixture as isolated
clusters in gene expression space [10, 11, 12, 13]. However, geometric methods do not provide
a natural language for mathematically representing a subpopulation of cells or statistical metrics
for quantifying shifts in population structure across experimental samples. PopAlign solves this
problem by modeling subpopulations of cells as parameterized probability densities within a com-
mon low dimensional space, and then, uses statistical metrics to track quantitative changes within
subpopulation specific densities across experimental samples.
We assess the accuracy and generality of PopAlign using twelve datasets from a mouse tissue sur-
vey (Tabula Muris) as well as new experiments on human peripheral blood cells in health and a
diseased state, multiple myeloma [14]. We show that PopAlign can identify and track cell-states
across a diverse range of tissues, signaling experiments, and human disease states. The probabilis-
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tic models have high representational accuracy and identify biologically meaningful cell-states
from data. In the immune system, we show that PopAlign identifies cell-type specific responses to
cytokines in primary human immune cells. Finally, PopAlign extracts general and treatment spe-
cific signatures of disease progression from multiple myeloma patient samples. Moving forward,
PopAlign sets the stage for the analysis of large-scale experimental screens of drugs and genetic
perturbations on heterogeneous cell populations extracted from primary human tissue samples.
Key Contribution
• Probabilistic modeling of cell populations enables alignment of cellular subpopulations across
experimental samples, and concurrent tracking of gene expression and cell abundance changes.
• Application of method to data sets from mouse tissues and primary human cells demon-
strates accuracy of models and ability to track cell-state specific gene expression changes in
response to signals and disease states.
Results
PopAlign represents heterogeneous cell populations with probabilistic mix-
ture models
We develop a mathematical and computational framework (PopAlign) that (i) identifies and aligns
cell-states across paired populations of single cells (a reference population and a test population),
and then (ii) quantifies shifts in cell-state abundance and gene expression between aligned popu-
lations (Figure 1). The method has three steps: probabilistic mixture model construction, model
alignment, and parameter analysis. PopAlign can be applied to analyze gene expression and pop-
ulation structure changes in heterogeneous populations of cells as they respond to signals, drugs,
and disease conditions.
We consider two populations of cells, a test and a reference population, (Dtest and Dref), that are
profiled with single cell mRNA-seq (Figure 1a). Profiling of each population generates a set of
gene expression vectors, e.g. DTest = {gi}ki=1 where g = (g1, g2, · · · , gn), is an n dimensional
gene expression vector that quantifies the abundance of each mRNA species in single cell g and k
is the number of profiled single cells.
To compare the reference and test cell populations, we first, construct a probabilistic model of
the gene expression distribution for each set of cells (Figure 1b). The high dimensional nature
of gene expression (n ∼ 20, 000) space makes the inference and interpretation of probabilistic
models challenging. Therefore, we represent each cell, not as a vector of genes, but as a vector
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of gene expression programs or gene expression features that are extracted from the data, so that
each single cell is represented as a vector c = (c1, c2 · · · cm) of m feature coefficients, ci, which
weight the magnitude of gene expression programs in a given cell(See Methods - Extraction of gene
feature vectors using matrix factorization). We extract these gene features using a particular matrix
factorization method called orthogonal non-negative matrix factorization (oNMF) that produces a
useful set of features because all vectors are positive and composed of largely non-overlapping
genes (See SI Figure 1b and 1g). This allows us to naturally think of a cell’s transcriptional state
as a linear sum of different positive gene expression programs.
Following dimensionality reduction, for a given cell population, we think of cell states as being
sampled from an underlying joint probability distribution over this feature space, P (c), that spec-
ifies the probability of observing a specific combination of gene expression features/programs, c,
in the cell population. We estimate a probabilistic model, P test(c) and P ref(c), for the reference
and test cell populations that intrinsically factors each population into a set of distinct subpopula-
tions each represented by a Gaussian probability density (density depicted as individual ‘clouds’
in Figure 1b):
P test(c) =
l∑
i=1
wi φ
test
i (c) (1)
where φtesti (c) = N (c;µi,Σi)
where N (c;µi,Σi) are multivariate normal distributions with weight wi; centroids µi and co-
variance matrices Σi. The distributions φtesti (c) = N (c;µi,Σi), mixture components, represent
individual subpopulations of cells; l is the number of Gaussian densities in the model. We estimate
the parameters of the mixture model ({µi,Σi, wi}) from single cell data using the expectation-
maximization algorithm [15, 6] with an additional step to merge redundant mixture components to
compensate for fitting instabilities (See Methods - Merging of redundant mixture components).
The parameters associated with each Gaussian density ,(µi,Σi, wi), have a natural correspondence
to the biological structure and semantics of a cellular subpopulation. The relative abundance of
each subpopulation corresponds to the weight wi ∈ [0, 1]; the average cell gene expression state
of each subpopulation corresponds to the (m dimensional) Gaussian centroid vector µi, and the
shape or spread of the subpopulation is captured by the covariance matrix Σi. Intuitively, the local
Gaussian densities provide a natural ‘language’ for comparisons between samples. Each Gaussian
is a region of high density in gene feature space, and we compare cell populations by asking how
the density of cells shifts across experimental conditions.
Statistical alignment of cellular subpopulations between samples
To compare the test and reference models, we ‘align’ each mixture component in the test population
model, φtesti (c) ∈ {φtesti (c)}, to a mixture component, {φrefi (c)}, in the reference population model
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(Figure 1c). Alignment is performed by finding the ‘closest’ reference mixture component in gene
feature space. Mathematically, to define closeness, we use Jeffrey’s divergence, a statistical metric
of similarity on probability distributions. We chose Jeffrey’s divergence over other metrics because
it is symmetric while also having a convenient parametric form (see Methods)
Specifically, for each φtesti ∈ {φtesti (c)}, we find an φrefj ∈ {φj(c)}ref, the closest mixture in the
reference set:
arg min
φrefj (c)∈{φrefj (c)}
DJD (φ
test
i (c) ‖ φrefj (c)), (2)
where the minimization is performed over each {φrefi (c)} in the set of reference mixtures, and DJD
is the Jeffrey’s divergence (14). Intuitively, for each test mixture, we find the reference mixture φj
that is closest in terms of position and shape in feature space. For each alignment, we then calculate
an explicit p-value from an empirical null distribution P (DJD) that estimates the probability of
observing a given value of DJD in an empirical data set of all subpopulation pairs within a single
cell tissue database (See Methods - Scoring alignments).
Tracking cell-state shifts through mixture model parameters
Following mixture alignment, we analyze quantitative differences in mixture parameters between
the reference and test models to track shifts in gene expression state, gene expression covariance,
and cellular abundances across the identified subpopulations of cells(Figure 1d). Mathematically,
for each aligned mixture pair, (φtesti , φ
ref
j ) with parameters {µrefi ,Σrefi , wrefi } and {µtestj ,Σtestj , wtestj },
we calculate:
∆µi = ||µrefi − µtestj ||2 (3)
∆Σi = DC(Σ
ref
i ,Σ
test
j ) (4)
∆wi = |wrefi − wtestj | (5)
where ∆µi measures shifts in mean gene expression; ∆wi quantifies shifts in cell-state abundance;
∆Σi quantifies shifts in the shape of each mixture including rotations and changes in gene expres-
sion variance (see Methods) [16]. We calculate these shifts in parameters for all mixture pairs to
assess the impact of signaling conditions or environmental changes on the underlying cell popula-
tion.
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PopAlign identifies and aligns cell-states across disparate mouse tissues
To test the accuracy and generality of PopAlign, we first constructed and aligned probabilistic
models across a wide range of mouse tissues from a recent public study (Tabula Muris) [14].
The Tabula Muris study contains single cell data collected from 12 different tissue samples with
∼ 40, 000 cells total.
For all tissues analyzed, the probabilistic mixture models produce an accurate and interpretable
decomposition of the underlying cell states (SI Figure 3). Accuracy of the models can be assessed
by comparing the synthetic (model generated) data to raw experimental data held out from model
training. PopAlign models generate synthetic data that replicates the geometric structures and
statistical variations found in the tissue data in tSNE or PCA plots with quantitative error of∼ 12%
error (See methods; Figure 2; 3a,b; SI Tissues; see methods).
In addition to providing an accurate representation, the mixture models decompose the cell pop-
ulations into a biologically interpretable set of cellular subpopulations represented by individual
φi(c), the mixture components (Figure 3c,d). The PopAlign mixture components, {φi(c)} com-
monly contain cells of a single cell ‘type’ as defined by the Tabula Muris project labels and, in
example tissues, PopAlign extracts known tissue resident cell-types including (Figure 3c,d) basal
cells, luminal cells, macrophages, and T-cells (in mammary gland) and skeletal muscle cells, mes-
enchymal stem cells, endothelial cells, and macrophages (in limb muscle). Broadly, across all
tissue models, 70% of the mixture components classified for a single cell-type provided by Tabula
Muris (SI Figure 3).
Through alignment of model components across tissues, PopAlign enables high-level comparisons
of tissue composition. By aligning Mammary Gland to Limb Muscle (Fig. 3e), we identified
‘common’ cell-types between the two tissues including B-cells (p=0.0006), T-cells (p=0.001), en-
dothelial cells (p=0.0013), and macrophages (p=0.004, 0.0076) (SI Fig 4), and also revealed tissue
scale differences in relative abundance. T-cells are highly prevalent (w = .3 in the mammary gland
but rare in the limb muscle w = .05) (Fig. 3g); endothelial cells are highly abundant in the limb
muscle (w = .32), but rare in the mammary gland (w = .06) (Fig. 3g). Between shared cell types,
such as macrophages, we reveal common programs such as FC-receptor Signaling and Lysosome,
as well as tissue-specific gene expression programs such as TGF-Beta, Phagocytosis, and Leuko-
cyte Chemotaxis(Fig. 3h). PopAlign can, thus, give insight into the underlying composition of a
tissue, shedding light onto principles of tissue organization with respect to tissue function.
PopAlign identifies subpopulation specific responses to cytokines in primary
immune cell populations
A key application of PopAlign is to study heterogeneous cell populations in the human body as they
respond to environmental change, drug treatments, and disease. The human immune system is an
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important application domain for PopAlign as an extremely heterogeneous physiological system
that is central for disease and cell engineering applications [2, 17, 18, 19, 20]. As a test case, we
asked whether PopAlign could identify subtype-specific signaling responses in a complex mixture
of primary human immune cells. Thus, we treated primary human peripheral blood mononuclear
cells (PBMCs) (Fig. 4a) with two lymphokines - granulocyte-macrophage colony-stimulating fac-
tor (GM-CSF)(Fig. 4b) and interferon-gamma (IFNG) (Fig. 4c) that are known to have a specific
impact on monocytes [21, 22] (See Experimental Methods).
Broadly, PopAlign found that both lymphokine signals impact gene expression in monocytes
(canonical and non-canonical) while driving minimal gene expression changes in T-cells. In the
reference PBMCs, we identified five independent cell densities (Fig 4a), and classified them using
canonical markers from the literature (Fig. 4d). We aligned the signal treated cell-populations
(Fig. 4c-d) to the PBMC data (Fig. 4a), finding that, for both signals, the monocyte popula-
tions (mixtures PBMC-1, PBMC-3) had the largest shifts in their average gene expression state
(—∆µ—> 0.04) (Fig 4f). While T-cell abundances changed (numbers), their mean cell states (µ)
had the lowest magnitude of gene expression shift.
Additionally, the PopAlign framework exposed that GM-CSF and IFNG exerted qualitatively
different classes of transcriptional effects. In the GM-CSF condition, both canonical and non-
canonical monocytes (mixture 1 and 3) respond to the signal ‘additively’ by activating a new gene
expression program called Chemokine Secretion/Leukocyte Migration pathway (Figure 4g bottom,
blue arrows) that includes genes such as CCL2 (Fig 4g,h, iii), and cystatin B (CSTB) while losing
the expression of ’Lysosome’ program, which includes genes such as LYZ and granulysin (GRN)
(Figures 4h: v, vi). We call the GM-CSF induced change in gene expression ‘additive’ because
both classes of monocytes respond with the same transcriptional changes, but these changes are
induced in addition to their baseline gene expression state (Fig 4g - black arrows).
Alternately, IFNG signaling generates a ‘convergent’ signaling response inducing both canonical
and non-canonical monocytes to a single new transcriptional state. IFNG leads to a single new
monocyte subpopulation that aligns most closely with ‘non-classical’ monocyte population(Fig
4b), but also has a high secondary alignment score for the ‘classical’ monocyte population (Fig.
4c, 4e - red x). We infer based on the disappearance of the ‘classical monocytes’ and the high
score of the secondary alignment, that IFNG drives both subtypes towards a new transcriptional
state that has up-regulation of pathways involved in antigen presentation and phagocytosis - ‘ER
Phagosome’, ‘IFN-Gamma signaling’, ’Antigen Processing and Presentation’ [21]. Genes upreg-
ulated include the known targets of IFNG STAT1(Fig. 4h -i) and also PSME2 (Fig. 4h - ii), a
proteasome gene involved in the non-lysosomal protein degradation pathway. The induced pro-
grams are consistent with literature showing that IFNG converts monocytes to macrophages, cells
that recycle cellular debris within the body [23, 24].
In this way PopAlign reveals cell-type specific signaling responses within a complex cell mix-
ture subject to a globally applied signal. PopAlign, further, enabled us to define distinct categories
of signaling responses, ‘additive’ and ‘convergent’, within a highly heterogeneous population of
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primary cells.
tSNE obscures association between cell-states following signal addition
PopAlign extracts and quantifies population level changes in the signaling data set that are obscured
by existing geometric techniques like tSNE. tSNE provides a low dimensional but non-linear em-
bedding of data points that seeks to preserve geometric features of the high dimensional data while
separating distinct cell-states into clusters [10]. Thus, in the tSNE embedding of the signaling data,
the relationships between cell-states (subpopulations) is often obscured because gene expression
changes can result in the formation of new, separate, and ‘distant’ clusters (Fig 5). For example,
in response to IFNG, the monocyte populations become separated in the two dimensional embed-
ding (Figure 5b) making association of these clusters pre- and post-signal complicated. Further,
tSNE does not provide natural metrics for quantifying distinct parameters of a point cluster, so
that abundance, mean, and shape all must be defined and quantified through heuristic approaches.
Unlike tSNE, PopAlign provides a precise framework for defining populations of cells and also for
calculating statistical similarity scores for individual subpopulations across samples by using the
Jeffrey’s divergence to measure changes in gene expression state, abundance, and covariance.
PopAlign discovers general and treatment-specific signatures of multiple myeloma
Given the success of the PopAlign framework in extracting cell-type specific responses in the
immune signaling data, we applied the method to study underlying changes in cell state due to
a disease process. As a model system, we applied PopAlign to compare human PBMC samples
from healthy donors to patients being treated for multiple myeloma (MM). Multiple myeloma is an
incurable malignancy of blood plasma cells in the bone marrow. Both the disease and associated
treatments result in broad disruptions in cell function across the immune system [25, 26, 27, 28]
further contributing to disease progression and treatment relapse. In MM patients, immune cells
with disrupted phenotypes can be detected in the peripheral blood[29, 27, 30]. An ability to monitor
disease progression and treatment in the peripheral blood could therefore provide a powerful new
substrate for making clinical decisions.
We obtained samples of frozen PBMCs from two healthy and four multiple myeloma patients
undergoing various stages of treatment (SI Table 1). We profiled > 5, 000 cells from each patient,
and constructed and aligned probabilistic models to one reference healthy population (Figure 6a-f).
PopAlign identified several common global signatures in the MM samples at the level of cell-type
abundance and gene expression. Across all samples, we find previously known signatures of multi-
ple myeloma including a deficiency in B cells [27, 31, 32], and an expansion of monocyte/myeloid
derived cells [29], and critically, new impairments in T-cell functions.
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Plotting ∆w across all patients, we find high-level changes in subpopulation abundances, which
are known to be prognostic of disease progression [30]. We find that all MM patients experience a
contraction in B cell numbers (Fig. 4b), and 2 out of 4 see a dramatic expansion (∆w >> .10) of
monocytes (Fig. 4c). Changes in T cell levels, however, can be highly variable, with outlier patient
MM4 experiencing a large increase in effector T cell (∆w = .2), and a complete elimination of
resting T cells (∆w = .2). For this patient, who was receiving a thalidomide-derived drug therapy,
these deviations are consistent with thalidomide’s known stimulatory effects on T-cells [33].
Especially in patients with apparently normal abundances (i.e. ∆w are small), uncovering subpopulation-
specific changes in transcription can point to specific modes of immune dysfunction. We use
PopAlign to find that monocyte subpopulations in patients acquire immunosuppressive pheno-
types, evidenced by upregulated expression of CD11b and CD33. Both genes are specific markers
of myeloid derived suppressor cells[34] which are negative regulators of immune function associ-
ated with cancer. By plotting the monocyte-specific mean gene expression values for both CD11b
and CD33, we see that all patients except patient MM3 score highly for both MSDC markers. (Fig
6k). Patients with high MDSC populations typically have a poor prognosis, underscoring the need
to monitor MDSC populations in patients.
Importantly, we also find that naive and effector T cells across all multiple myeloma patients have
transcriptional defects in pathways essential for T cell function. By plotting ∆µ, we show that
both populations of T cells experience large mean transcriptional shifts, compared to T cells from
our second healthy donor, healthy2 (Fig. 6m). By examining the µ′s in terms of gene expression
vectors (Fig. 6n), we find that in multiple myeloma, T cells reduce their expression of two key
features - Leukocyte Motility, and Cytotoxic Lymphocyte Killing. Surprisingly, the impact on
motility is apparent even on the expression of beta-actin (ACTB) (Fig. 6o), a core subunit of the
actin cytoskeleton, and which was the top hit in the Leukocyte Motility feature. We find similar
declines in the distribution of Perforin 1 (PFN1), a pore-forming cytolytic protein that was found
as a top hit in the Cytotoxic Lymphocyte program (Fig. 6p).
Our analysis establishes that we can extract consistent and also patient-specific transcriptional
signatures of human disease and treatment response from PBMCs. Interpreting these signatures in
the context of disease progression or drug response can provide insight into treatment efficacy and
can form the basis of a personalized medicine approach. Our framework enables new applications
by providing a highly scalable way of extracting, aligning, and comparing these disease signatures,
across many patients at one time.
Discussion
In this paper, we introduce PopAlign, a computational and mathematical framework for tracking
changes in gene expression state and cell abundance in a heterogeneous cell populations across
experimental conditions. The central advance in the method is a probabilistic modeling framework
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that represents a cell population as a mixture of Gaussian probability densities within a low dimen-
sional space of gene expression features. Models are aligned and compared across experimental
samples, and by analyzing shifts in model parameters, we can pin-point gene expression and cell
abundance changes in individual cell populations.
PopAlign constitutes a conceptual advance over existing single cell analytical methods. PopAlign
is explicitly designed to track changes within complex cell populations. Since human diseases
like cancer and neurodegeneration arise due to interactions between a wide variety of cell-types
within a tissue, population level models will be essential for building a single cell picture of human
disease and for understanding how disease interventions like drug treatments impact the wide range
of cell-types within a tissue.
Mathematically, existing single cell analysis methods rely on heuristic cluster based analysis to
extract subpopulations of cells. Fundamentally, such approaches lack well defined statistical met-
rics for making comparisons across samples. By conceptualizing a single-cell population as a
probability distribution in gene expression space, we define a discrete mathematical objects whose
parameters can be interpreted, and which can be used to explicitly calculate quantitative statistical
metrics for subpopulation alignment. Our probabilistic representation allows us to quickly and
scalably learn drug responses even on a complex mixture of cells, in ‘one shot’. Computationally,
PopAlign scales to analyze many samples that each contain thousands of single cells. We anticipate
applying the method to analyze data from drug screens where the goal is to identify cell-population
specific transcriptional responses.
In the future, we hope that PopAlign can be used as a part of a work-bench for single cell analy-
sis and treatment of human disease. By applying PopAlign to data sets from the human immune
system, we highlight the potential power of PopAlign for identifying drug/signal targets and for de-
constructing single cell disease states. PopAlign identified cell-type specific signatures of disease
treatment in multiple myeloma patients exposing a potential defect in T-cell activation and motility
in three patient samples. This result points to a potential use of PopAlign for guiding treatment
interventions by exposing the spectrum of transcriptional states within a diseased tissue and reveal-
ing the impact of drug treatments on diseased cell-states as well as the cellular microenvironment
and immune cell-types. Such insights could lead to single cell targeting of drug combinations to
treat human disease as an essentially population level phenomena.
Methods
Mathematical framework
We consider two populations of cells, a reference population, (Dtest and Dref), and a test pop-
ulation. Following profiling by single cell mRNA-seq, each population of cells is a set of gene
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expression vectors, D = {gi}ki=1 where k is the number of cells in the population, and g =
(g1, g2, · · · , gn), is an n dimensional vector that quantifies the abundance of each mRNA species.
While raw mRNA-seq measurements generate integer valued gene count data, due to measurement
noise and data normalization, we consider g to be embedded in an n dimensional Euclidean vector
space, gene expression space, g ∈ Rn. The high dimensional nature of gene expression space
poses the key challenge for construction and interpretation of statistical models.
We think of the gene expression vectors, {gk} as being distributed according to an underlying
probability density function, P (g), that quantifies the probability of observing a particular joint
gene expression state, g = (g1, g2, · · · , gn), in a given cell population. Our broad goal is to es-
timate a statistical model of P (g),based upon single cell measurements. The model provides a
parametric representation of the gene expression density in each condition. Then, we seek to use
this representation to track changes in the structure of the cell population across conditions.
In general, the mathematical challenge we face is model estimation in the high dimensional na-
ture of gene expression space. For human cells n > 20, 000, and single cell profiling experiments
can routinely probe 10,000 cells per sample. The number of parameters in our probabilistic models
scales quadratically with n, and mixture model learning has data requirements that are exponen-
tial in n [8]. Therefore, we first reduce the dimensionality of the problem by building models in
a common low dimensional space defined by gene expression programs discovered from pooled
data across all samples.
Data normalization
Single cell gene expression data must be normalized to 1) to account for the variation in the number
of transcripts captured per cell and 2) to balance the wide disparity in the scale of values across
different genes due to measurement noise and gene drop-out.
The total number of transcripts captured for each single cell can vary from 1000 to 100,000 unique
transcripts per cell. Technical variability in reagents and library prep steps can have a large impact
on the number of transcripts retrieved per cell. To scale out these differences, we divide each gene
expression value gi by the total number of transcripts and then multiply by a scaling factor β.
Additionally, across genes, mean transcript values can span 5 orders of magnitude. Transforming
the data using the logarithm brings values across all genes close in scale, while also reducing the
skew in the data distributions. The equation for transforming a raw gene expression value gi (for a
single gene) into a normalized gene expression value, g′i is:
g′i = log(β
gi∑n
i gi
+ 1) (6)
where n is the total number of genes, and β is a scaling factor, and we add a 1 pseudo-count to each
gene expression value. We found that by setting β = 1000 to be roughly the minimum number of
total transcript counts in a cell (1000 transcripts), we achieve a smooth transition in the distribution
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of transformed g′i when raw gi values step from 0 to 1. Gene expression values are thus denoted in
units of log(TPT+1) where TPT is transcripts per thousand.
Extraction of gene feature vectors with matrix factorization
We circumvent the curse of dimensionality ([7]) by building models in a common low-dimensional
space defined by gene expression features or programs. Mathematically, we represent the tran-
scriptional state of each single cell, g, as a linear combination of gene expression feature vectors,
{fi}:
g =
m∑
i=1
ci fi (7)
where fi ∈ Rn specifies a gene expression feature, and ci is a coefficient that encodes the weighting
of vector fi in g, the gene expression state of a single cell. The key result in [7] is that a cell’s
gene expression state, g can be represented as a linear combination of m gene expression module
vectors, fi where m << n. This insight allows us to construct a low dimensional representation
of a cell population and, then, to estimate statistical models within the low dimensional space.
[7, 35, 36].
The gene features, {fi} can be extracted using a wide range of matrix factorization and machine
learning technique including Singular Value Decomposition, and its matrix factorization relatives
like sparse PCA as well as methods like layered neural networks [7]. We use a technique called
orthogonal non-negative matrix factorization [37] (oNMF) to define a space of orthogonal gene
expression features vectors. Like other linear dimensionality reduction techniques, such as PCA,
oNMF factors the original data matrix, Dtrain (SI Fig. 1a) into two matrices D ≈ F C (SI Fig.
1b,c). Factorization occurs through minimization of an objective function with positivity and or-
thogonality constraints:
arg min
F ,C
||Dtrain − FC||2
subject to F TF = I, Cij ≥ 0, Fij ≥ 0, (8)
The optimization minimizes the (Frobenius) norm of the difference between the training data,
Dtrain, and its factored representation FC. The columns of F contain gene features, fi. The
matrixC is m by k, where k is the number of single cells inDtrain. Each column ofC encodes the
weighting of them gene features across a given single cell. The entries ofF andC; are constrained
to be positive, and the columns of F (the gene features) are constrained to be orthogonal. F is an n
by m matrix (genes by features). Each column contains n weights where each weight corresponds
to the weight of a given gene in that feature, fi.
Standard non-negative matrix factorization has been shown to provide a useful set of features for
gene expression analysis because feature vectors have positive entries, and so we can naturally
think about the gene expression state of a cell, g, as being assembled as a linear sum of positive
gene expression programs.
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In PopAlign, we incorporate orthogonality in F as a secondary constraint to aid interpretation.
Empirically, we found that orthogonality aids in interpretation of the features as well as in model
construction because the orthogonal gene expression features are interpretable as non-overlapping
sets of genes (SI Fig. 1b) that can individually be analyzed by gene set enrichment analysis (SI
Fig. 1f)(see Methods - Gene Set Enrichment Analysis). Second, orthogonality tended to force
individual cell states to be represented by more than one feature which aided stability during model
parameter estimation.
To perform oNMF, we select m, the number of features to be extracted through an optimization
that balances accuracy and dimensionality explicitly. In oNMF (as opposed to PCA and SVD),
m is a parameter given to the optimization. Choosing m involves balancing the tension between
the ’expressiveness’ in the feature set and its dimensionality. Higher m reduces the error in the
representation while also breaking up blocks of genes into smaller modules that represent inde-
pendent gene expression pathways with finer granularity. However, as m increases, the typical
computational and sampling challenges associated with high dimensionality emerge.
Practically, we balance this tension in PopAlign by constructing a loss function with a penalty that
increases with m:
arg min
m
f(m) = ||Dtrain − FmCm||2 +mα. (9)
For each value ofm, we perform oNMF onDtrain yielding Fm andCm, and thus an error ||Dtrain−
FmCm||2. This error is, then, incremented by the termmα which penalizes higher values ofm and
hence the dimensionality of the feature set. We set α = .7 based upon numerical experimentation
on model data sets (SI Figure 2). For any choice of m, we can estimate the accuracy of the
representation by plotting reconstructed data FC (SI Figure 1d) against normalized data D (SI
Figure 1a). The SI shows such plots and the PopAlign software package outputs these plots by
default.
Practically, given data sampled a set of cell populations,(eg Dtest1 , Dtest2 , Dref) we pool data from
all cell populations into a training data set, Dtrain, and perform oNMF. If we are analyzing a large
number of data sets or sets with many single cells, we generateDtrain by sampling 500-1,000 cells
uniformly at random from the reference and test cell populations and selecting a m via ((9)).
Because the feature vectors are not always purely orthogonal, we recast the complete dataset into
the feature space using a non-negative least squares. Specifically, for each gene expression profile,
g, we find, c via:
arg min
c
||g − F c||2 (10)
ci ≥ 0
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where F is a fixed feature set learned from oNMF on Dtrain. The gene expression vector g is thus
compressed into a k-dimensional vector ci that provides a high-level programmatic representation
of cell state in terms of gene expression ‘features’. Finally, we interpret the biological meaning
of the feature vectors in terms of annotated gene expression programs using gene set enrichment
analysis (see Methods - Gene Set Enrichment Analysis).
Using matrix factorization, we map a cell population, D = {g}, from an n ∼ 20, 000 dimensional
gene expression space into a gene feature space that is often of order 10− 20 dimensions [7].
D = {gi} → {ci},
where {ci} are m × 1 dimensional vectors that now represent the cell population in the reduced
gene feature space.
Gene set enrichment analysis
To interpret the gene features in terms of annotated gene sets, we perform geneset enrichment
analysis using the cumulative hypergeometric distribution. We define each feature vector by the
collection of genes that have weightings greater than 4 times the standard deviation (> 4σ). Using
this collection of genes, we can then calculate the null probability of drawing k genes (P (X > k))
from a specific annotated gene set using the hypergeometric cumulative probability distribution:
P (X > k) =
k∑
i=1
(
Y
i
)(
N−Y
Z−i
)(
N
Z
)
, where N is the total number of genes, Z is the number of genes in the feature that are > 4σ, Y
is the number of genes in each annotated gene set, and k is the number of genes that overlap with
annotated gene set.
Gene sets are sorted by their associated null probability; the 10 gene sets with the lowest null
probabilities are reported for each feature. The gene sets in our dictionary are pulled from GO,
KEGG, and REACTOME, and are supplied with our code. SI Figure 1f shows an example of gene
set enrichment results for two features.
oNMF error analysis
The error associated with each feature set Fm was assessed by comparing data entries between
a cross validation dataset Dx and its reconstructed matrix FmCx. We binned the data in Dx
into bins of equal width ∼ 0.1 (in units of log(TPT+1)). We retrieved data values from each
bin, (Dx)bin, and then plotted their means against the means of corresponding data values in the
reconstructed matrix, (FmCx)bin (SI Figure 1d). The standard error in each bin is calculated as
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the mean squared deviation of the reconstructed data from the original data:
σbin =
√∑n
i ((FmCx)i − (Dx)i)2
n
, ∀ i ∈ bin
To quantify the amount of dispersion relative to the mean, we also calculate the coefficient of
variation for each bin:
CVbin =
σbin
(Dx)i
, ∀ i ∈ bin
We find empirically that the average CV is ∼ 30− 35% across all bins for most feature sets.
Representing a cell population as a Gaussian Mixture Model in gene feature space
Following the feature based representation, we construct a statistical model of each given cell pop-
ulation within the reduced gene feature space. Mathematically, we have exchanged a probability
distribution in gene expression space for a probability distribution in gene feature space:
P (g)→ P (c), (11)
where g is n× 1 and c is m× 1, and m << n. We can now estimate a statistical model of P (c).
To account for the heterogeneity of cell-states within a tissue, we model cell-populations using
Gaussian mixture models. Gaussian densities provide a natural representation of a transcriptional
state in gene expression space which is consistent with measured gene expression distributions as
well as empirical models of transcription [38, 39, 40]. Theoretical models of stochastic transcrip-
tion commonly yield univarite gene expression distributions where mRNA counts are Poisson or
Gamma distributed. Normal distributions provide a reasonable approximation to these distribu-
tions with a computationally tractable inference procedure.
We represent the cell population as a mixture of Gaussian densities, so that for a given cell popu-
lation D, we construct:
P̂ (c) =
l∑
i=1
wi φi(c) (12)
φ(c) = N (c;µi,Σi)
where P̂ (c) is a mixture of Gaussian densities, N (c;µi,Σi), with centroid, µi; covariance ma-
trix, ,Σi; and scalar weighting wi. µi is a vector in the m dimensional feature space, and Σi is a
symmetric m × m matrix. l is the number of Gaussian mixtures or components in the statistical
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model. The Gaussian mixture model (GMM) represents a cell populations as a mixture of individ-
ual Gaussian densities. Biologically, we think of each density as parameterizing a subpopulation
of cells.
We can estimate the parameters µi, Σi, and wi based upon training data, using maximum like-
lihood estimation with likelihood function:
L({µi,Σi, pii}|D′) =
k∑
j=1
logP (cj ; {µi,Σi, wi}), (13)
where cj are single cell profiles drawn from a cell population D′ and cast into feature space; k is
the number of single cells in the cell population D′. For a given experimental data set, L defines
a function over the space of model parameters. To select model parameters given data, we can
attempt to maximize the value of L. In general for Gaussian Mixture models, likelihood maximum
is complicated by the geometry of L which is not concave and can have multiple local and global
maxima [41]. L can be maximized approximately using expectation maximization.
Expectation-maximization is a heuristic algorithm that finds (local) maximum likelihood parame-
ters. Although it is known to have fundamental problems - including weak performance guarantees
and a propensity to overfit data, new methods [8] place constraints that are invalid for our appli-
cation (such as shared covariance matrices). We find empirically that the EM algorithm performs
well, learning low-error representations of c (SI Fig. S2), and that we can overcome fitting insta-
bilities by algorithmically merging components. Practically, we perform expectation maximization
using sci-kit learn. We regularize the variance of individual mixtures to constrain variance to be
non-zero to avoid fitting instabilities. We determine mixtures number through the Bayesian Infor-
mation Criterion (BIC) which optimizes a trade-off between model complexity and accuracy on
training data.
Merging of redundant mixture components
One drawback of the EM algorithm is its propensity to fit ’redundant’ mixture components to the
same local density with significant overlap. For our application, this redundancy complicates in-
terpretation and comparisons across samples. We overcome this problem by taking advantage of
mixture model properties to algorithmically merge redundant mixtures using the Jeffrey’s diver-
gence.
For multivariate Gaussian distributions, the Jeffrey’s divergence has a closed analytic form.
DJD(φi‖φj) = 1
2
(DKL(φi‖φj) +DKL(φj‖φi)) (14)
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where φ0 and φ1 are two independent components from the same mixture model (12), and µ and
Σ are their associated parameters.
DKL is the Kullback Leibler divergence and has a convenient parametric form for Gaussian distri-
butions:
DKL(Ni(c;µi,Σi)‖Nj(c;µj ,Σj)) = 1
2
(
tr
(
Σ−1i Σj
)
+ (µi − µj)T Σ−1i (µi − µj)− k + ln
(
det Σi
det Σj
))
For each mixture model, we iteratively attempt to merge component pairs with the lowest Jeffrey’s
divergence and accept mergers that increase the BIC of the model given the data. With each merge
step, model parameters for candidate pair are recalculated, and the updated model is accepted or
rejected based on the new BIC. Mergers are performed until the first rejection. This procedure
removes redundant mixture components from the model.
Sampling data from Gaussian mixture models
Given parameters, {(µi,Σi, wi)}li=1 for a given mixture model. We can ‘generate’ synthetic data
from the model through a simple sampling procedure. A given model has, l mixtures, and we first
select a mixture from the set of l mixtures with probabilities weighted by wi. Following selection
of a mixture, j, we use standard methods to draw a ‘point’ in them dimensional feature space from
N|(c,µj ,Σj).
Analysis of model error
Model error was assessed by comparing the distribution of model generated data to the empirical
data. To avoid under-sampling, we performed error analysis within two dimensional projections
of the data and averaged error over all 105 projections. Briefly, each projection was binned into 25
bins. In each bin, the deviation between the model generated data and empirical data was calculated
as percent error, Nd−Nm
Nd
, where Nd and Nm are, respectively, the number of data of empirical and
model generated data points in a given bin. Total error within each projection is calculated as a
weighted average of this percent error over all bins in a projection:
error =
∑
i
Ni
NT
|Ni − N̂i|
Ni
,
where Ni is the number of experimental data points in bin i, and N̂i is the number of model gener-
ated data points in bin i. NT is the total number of experimental data points. This metric weights
the per-bin fractional error by the probability density of each binned region in the projection.
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Alignment of models across reference and test populations
To compare the test and reference models, we ‘align’ each mixture component in the test population
model, φtesti (c) ∈ {φtesti (c)}, to a mixture component, {φrefi (c)}, in the reference population model
(Figure 1c). Alignment is performed by finding the ‘closest’ reference mixture in gene feature
space. Mathematically, to define closeness, we use, Jeffrey’s divergence, a statistical metric of
similarity on probability distributions. Specifically, for each φtesti ∈ {φtesti (c)}, we find an φrefj ∈
{φj(c)}ref, the closest mixture in the reference set:
arg min
φrefj (c)∈{φrefj (c)}
DJD (φ
test
i (c) ‖ φrefj (c)), (15)
where the minimization is performed over each {φrefi (c)} in the set of reference mixtures, and DJD
is the Jeffrey’s divergence (14). Intuitively, for each test mixture, we find the reference mixture φj
that is closest in terms of position and shape in feature space.
For each alignment, we then calculate an explicit p-value from an empirical null distribution
P (DJD) that estimates the probability of observing a given value of DJD in an empirical data
set of all subpopulation pairs within a single cell tissue database. Aligning subpopulations us-
ing Jeffrey’s divergence incorporates information about the shape and position of the probability
distributions (i.e. covariance), while disregarding the relative abundance of each subpopulation.
Scoring alignments
To assign a p-value to alignments, we calculate the probability of observing two cell-states with a
given Jeffrey’s divergence by chance using an empirical null distribution generated from the tissue
data set. Specifically, we constructed a mixture model for all tissue pairs in Tabula Muris. Then, we
calculate all pair-wise Jeffrey’s divergence scores for all the underlying mixtures. This calculation
gives us a global distribution over DJD for cell-states in the mouse. This distribution provides a
null distribution for typical statistical closeness between cell-states in feature space.
Model interpretation through parameter analysis
Following mixture alignment, we analyze quantitative differences in mixture parameters between
the reference and test sample to track shifts in gene expression state, gene expression covariance,
and cellular abundances across the identified cell-states in the cell population.
Specifically, for each aligned mixture pair, (φtesti , φ
ref
j ) with parameters {µrefi ,Σrefi , wrefi } and {µtestj ,Σtestj , wtestj },
we calculate:
18
(which was not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint. http://dx.doi.org/10.1101/421354doi: bioRxiv preprint first posted online Sep. 21, 2018; 
∆µi = ||µrefi − µtestj ||2
∆Σi = DC(Σ
ref
i ,Σ
test
j )
∆wi = |wrefi − wtestj |
where ∆µi measures shifts in mean gene expression; ∆wi quantifies shifts in cell-state abundance;
∆Σi quantifies shifts in the shape of each mixture including rotations and changes in gene ex-
pression variance . We calculate these shift parameters for all mixture pairs, and then analyze the
shifts to assess the impact of signaling conditions or environmental changes on the underlying cell
population.
DC(Σi,Σj) =
√√√√ m∑
z=1
ln2 λz(Σi,Σj)
where λz is a generalized eigenvalue of Σi and Σj or a solution to Σi v = λzΣjv , and m is again
the number of gene features.
Classification of mixtures using marker genes
For the Tabula muris data set, cells and mixtures were classified using cell-type annotations pro-
vided by the study. Mixtures were classified according to the cell-type with the maximum abun-
dance within a given mixture (Figure 2).
For immune cell experiments, we classified the independent mixture components as effector T
cells (CD3+/CD57+), naive T-cells(CD3+/CD28+), erythrocytes (HBB+), canonical monocytes
(CD14+/CD16low), and nonclassical monocytes(CD14low/CD16++)[42] (Fig 4e). We aligned
populations in our test samples - GM-CSF (Fig 4b) and IFNG (Fig. 3c) - to the reference popula-
tions (control) by finding pairs of components that minimize the Jeffrey’s divergence (Fig 4d).
Software implementation
PopAlign has been implemented within our LOWMIX software infrastructure package. It is writ-
ten in Python3 and requires common scientific computing libraries (numpy, matplotlib, pandas,
seaborn, tables, MulticoreTSNE, adjustText) that can be easily installed with pip and our require-
ments file. A guide on how to get set up and install dependencies is provided on the packages
Github page. The software runs on local machines, as well as on Amazon Web Services headless
EC2 instances, providing a powerful setting for large-scale analyses. The architecture of this pack-
age is built around classes that store experimental samples as objects and provide a set of specific
methods to perform tasks such as normalization, dimensionality reduction, model construction,
model alignment, and parameter comparison.
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Experimental methods
Single-cell RNA-sequencing. Cryopreserved PBMCs (healthy and disease samples) from Hemacare
were thawed in a 37C waterbath for 2 minutes after which the cells were transferred to a 15mL con-
ical tube. Prewarmed RPMI1640 was then added to the 15mL conical to a final volume of 10mL
and centrifuged for 2 minutes at 300RCF to pellet the cells. Supernatant was removed and cells
were resuspended to 1 million cells/mL in RPMI1640 supplemented with 10% FBS and 17,400
cells were loaded into each TENX lane.
PBMC signaling experiment. Cryopreserved PBMCs sourced from Hemacare (∼ 10 million
cells, source ID: D23127, Lot: 17043194) were thawed in a 37C waterbath for 2 minutes after
which the cells were transferred to a 15mL conical tube. Prewarmed RPMI1640 was then added
to the 15mL conical to a final volume of 10mL and centrifuged for 2 minutes at 300RCF to pellet
the cells. Supernatant was removed and cells were resuspended in 10mL of RPMI1640 supple-
mented with 10% FBS and 1% pen/strep. The cell suspension was then plated onto a 100mm low
attachment plate and placed in a CO2 incubator at 37C for 5 hours for the cells to recover.
For each condition, 700,000 cells were aliquoted into a well of a 96well plate. These cells were
cultured for 13hours under two different conditions: 1) IFN- @1ng/mL, 2) GM-CSF 1ng/mL,
each with a single additional replicate. After incubation, the plate was sealed with an aluminum
adhesive and centrifuged for 3minutes at 300RCF. Supernatant was removed and replaced with
40L of TrypLE and incubated for 2 minutes before transferring cells to two 1.5mL Eppendorf
tubes, one for each culture condition.
Both tubes were centrifuged and the cells were resuspended to 5 million cells/mL in PBS+ 1%
FBS. 180L from each cell suspension processed using BDgenomics multiplexing kit and 8,000
cells from each condition were combined and run through a single TENX lane.
Figure Captions
Figure 1. Summary of PopAlign framework PopAlign provides a scalable method for decon-
structing quantitative changes in population structure including cell-state abundance and gene ex-
pression across many single cell experimental samples. (a) Users input PopAlign single-cell gene
expression data from a ’Reference’ sample, and at least one ’Test’ sample, which are each a col-
lection of n-dimensional gene expression vectors g, shown as single dots. (b) For each sample,
PopAlign estimates a low-dimensional probabilistic model that represents the distribution of gene
expression states as a mixture of local Gaussian densities φi with parameters encoding subpop-
ulation abundance (wi), mean gene expression state (µi), and population spread (Σi). PopAlign
reduces the dimensionality of the input data by representing each gene expression vector as set of
m gene expression features (m = 10−20), thus representing each cell as anm-dimensional vector
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of coefficients c. (c) Each φtesti in the test population is aligned to the closest φ
ref
i in the Reference
sample by minimizing Jeffrey’s divergence. (d) Following alignment, the parameters of aligned
subpopulation pairs are compared to identify subpopulation-specific shifts in cellular abundance
∆w, shifts in mean gene expression state ∆µ and shifts in subpopulation shape ∆Σ.
Figure 2. PopAlign models represent experimental data with high qualitative and quanti-
tative accuracy (a) Experimental data for ∼ 3600 bone marrow cells projected into an m = 15
dimensional gene feature space. 2D plots show single cells projected along gene feature pairs (ci,
cj), and a single selected 3D projection (inset) is shown. Blue axis denote shared axis between 2D
and 3D plot. (b) Model generated data for the same 2D and 3D feature space projections shown
in (a). In the 3D projection (inset), each maroon circle denotes the centroid (µ) of a Gaussian
mixture component where the circle radius is proportional to wi, the mixture weight. In all cases,
the model generated data replicates the qualitative geometric structures in the experimental data.
(c) Model error across 2D projections from (a) and (b) quantified by analyzing percent deviation in
point density for experimental vs model generated data. Quantification of error is performed using
a numerical error metric based on binning the 2D projections (See Methods - Analysis of model
error). The quantitative error in model-generated is on average 11.3% (red line) compared with
8.5% error when comparing random sub-samples of experimental data (blue line).
Figure 3. Probabilistic models identify, align, and dissect cellular subpopulations across dis-
parate tissues Experimental single-cell data (black) for two tissues, mammary gland (a) and limb
muscle (b), are plotted together with PopAlign model-generated data (teal) using a 2D t-SNE
transformation. Both experimental datasets contain ∼ 3600 cells. For each tissue, mixture model
centroids (µ) are indicated as numbered disks. (c-d) For models from both tissues, mixture com-
ponents (x-axis) are scored using cell type annotations supplied by Tabula Muris (y-axis). Each
cell of the heatmap represents the percentage of cells associated with each mixture component that
have a specific cell type label. Columns (but not rows) sum to 1. (e) Alignments between mixture
component centroids (µ) from the reference population (Mammary Gland) and the test population
(Limb Muscle) are shown as connecting lines. All m-dimensional mu vectors are transformed
using principal components analysis (PCA) and plotted using the first 3 PCS. Width of each line
is inversely proportional to the p-value associated with the alignment (see Legend). (f) Null distri-
bution of Jeffrey’s divergence used to calculate p-values. Jeffrey’s divergence was calculated for
all possible pairs of mixture components from models of all tissues from Tabula Muris. (g) We
rank aligned subpopulations in terms of maximum ∆w and show top two pairs. These subpopu-
lations are identified as T cells and endothelial cells, and are highlighted using a blue dotted line
in (e). We find that T cells are highly abundant in Mammary gland while endothelial cells are
highly abundant in muscle. (h) Comparing subpopulation centroids (µ) for macrophages in terms
of gene expression features. Macrophages in Mammary gland and Limb Muscle share common
features (black font), but also have tissue-specific features (red font). Corresponding alignments
are highlighted in (e) with a gray dotted line.
Figure 4. PopAlign identifies cell-type specific signaling responses in primary human im-
mune cells (a) Experimental data from reference PBMC sample (∼ 1300 cells) are projected into
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a 17-dimensional feature space, but are plotted in a 3D subset of features that are found to be
impacted by signals. Mixture model centroids (µ) are indicated as numbered disks. (b) Classi-
fication of mixture model components using mean gene expression values for canonical markers
of immune cells. Classical monocytes are CD14+, non-classical monocytes are CD14low/CD16+,
effector T cells are CD3D+/CD57+, naive T cells are CD3D+/CD28+, B cells are CD19+, and
Erythrocytes are HBB+. All gene means are calculated across cells scored by that mixture com-
ponent, and independently scaled by its max value across all mixture component means (including
subpopulations for signaling conditions). (c) Experimental data from cells exposed to GM-CSF,
with mixture component centroids denoted in orange. (d) Experimental data from cells exposed
to IFNG, with mixture component centroids denoted in light blue. Both test samples (GM-CSF
and IFNG) are aligned to the reference population, with specific alignments for reference mixture
components that classify as monocytes (overlaid and shown with connected lines). Shifts in the
position of the mixture component µ′s reveal how GM-CSF and IFNG exert differential effects
on monocyte populations. (e,f) For each mixture component from test samples (x-axis), Jeffrey’s
divergence against all reference components is plotted on a log10 scale, with lowest divergence
values giving the best alignment. Colored symbols correspond to alignments displayed in (c) and
(d). Black cross in (d) and (f) denotes a high secondary alignment for IFNG mixture 1, suggesting
that both PBMC-1 and PBMC-3 converge to the same final population in response to IFNG. (g)
Scatterplot of parameter changes ∆µ and ∆w for all subpopulation alignments across both test
samples. Monocytes have above average (∆µ ≥ 0.04) for both test samples. (h) Heatmap of
aligned monocyte mixture component centroids (µ) in terms of gene expression features. IFNG
(upper) induces expression of an ER Phagosome feature (blue arrow). GM-CSF alters expression
of two features (Chemokine Activity and Lysosome) but does not affect each subpopulation’s base-
line levels for 3 monocyte specific features (black arrows). (i) Abundances (w) are shown for both
sets of aligned subpopulations. (j) Gene expression distributions for all monocyte subpopulations
for specific genes from (h) that are affected by signals (blue arrows): (i) STAT1, a signal transducer
(ii) PSME2, a proteasome activator, (iii) CCL2, an inflammatory chemokine, (iv) CSTB, a protease
inhibitor, (v) LYZ, an antimicrobial enzyme, and (vi) GRN, a lysosomal protein.
Figure 5. t-SNE analysis obscures the relationships between aligned subpopulations (a-c)
tSNE plots of single cell data for three signaling conditions from Figure 4: (a) PBMC, (b) GM-CSF,
and (c) IFNG. Mixture component µ′s (disks) for PBMC mixture components 1 and 3 overlaid
on plots (b) and (c) to aid interpretation. PopAlign generated alignments for monocyte mixtures
from figure (3) are indicated as lines. tSNE was performed on data pooled from all experiments,
but experimental conditions are shown individually for clarity. Plot shows that gene expression
changes due to signaling can result in relative cluster shifts within the tSNE plots that obscure
subpopulation alignment. For example, in (b) the monocyte populations aligned by PopAlign
(Figure 4) become separated by a cluster of T-cells (mixture components 3 and 4).
Figure 6. Discovering signatures of disease and treatment in PBMCs from multiple myeloma
patients (a-f) Experimental single cell mRNA-seq data from two healthy donors and four multiple
myeloma patients (MM1-4) are projected into 16-dimensional gene feature space. 3D plots show
single cells in a subset of three gene features that highlight separation between different immune
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cell types. Mixture model centroids (µ) are indicated as numbered disks. Subpopulations in test
samples are aligned to the reference (a) and changes in abundance (∆w) are plotted for (g) B cells,
(h) monocytes, i) naive T cells, and j) effector T cells, showing general and patient specific changes.
(k) Mean gene expression levels for two markers of myeloid derived suppressor cells (MDSC),
CD33 and CD11b, are plotted for all monocyte subpopulations. Error bars denote confidence
interval of the mean. (m) |∆µ| for naive T cell and effector T cell populations relative to healthy1.
(n) Heatmap of mixture component µ vectors in terms of feature coefficients ci for aligned naive
and effector T cells across samples. MM subpopulations exhibit reduced expression of two features
(red font): Leukocyte motility and Cytotoxic Lymphocyte Killing. (o) Distribution of beta-actin
(ACTB) expression for all effector T cell subpopulations across samples. Violin shows distribution,
and mean is denoted by white circle. (p) Distribution of perforin 1 (PFN1) expression for all
effector T cell subpopulations across samples. For single gene plots (k), (o), (p), units are in terms
of normalized and transformed gene expression (log(TPT + 1)) where TPT denotes transcripts per
thousands.
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